Contrast-enhanced digital mammography is an advanced modality of breast imaging, which helps in improvement of the breast cancer screening process. Contrast-enhanced digital mammography generates a contrast-enhanced, full-field, and high-resolution image of digital mammography, similar to MRI, to provide lesion vascularity details inside the breasts. The technology combines the standard, full-field digital mammography (FFDM) with a low-osmolarity, intravenous, iodinated contrast medium. Detecting malignancies in extremely dense and heterogeneous breasts with the help of MRI is difficult. Contrast-enhanced digital mammography highlights the malignant area with the help of a contrast agent, facilitating the tumor detection. In contrast-enhanced digital mammography, an iodine-based contrast medium is administered intravenously in the arm vein before capturing the mammographic image and two subsequent images at low energy and high energy are obtained. The low-energy image reveals calcification and soft tissue details. The two images are then subtracted to generate a single, contrast-enhanced digital image, which highlights the neovascularity inside the breasts. Owing to the fact that cancerous tissues take up more iodine than normal tissues, the resulting contrast-enhanced image maximizes the conspicuity of the contrast agent in the breasts. This reveals the lesions with higher neovascularity and approximately ten times the resolution of the normal breast MRI.
The superiority of contrast-enhanced digital mammography over the breast MRI and standard mammography in detecting breast tumors, rising prevalence of the breast cancer across the globe, and cost-effectiveness of the contrast-enhanced digital mammography modality are major factors estimated to fuel the contrast-enhanced digital mammography market during the forecast period. However, lack of awareness about the contrast-enhanced digital mammography technology among the people in developing countries is anticipated to restrain the market during the forecast period.
Request COVID Analysis on Contrast-enhanced Digital Mammography (CEDM) Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=35984
The global contrast-enhanced digital mammography market has been segmented based on image type and end-user. Based on image type, the market has been segmented into 2D images and 3D images. The 2D images segment dominated the market in 2016, due to rising awareness about the contrast-enhanced digital mammography procedure in developing countries. On the other hand, the 3D image segment is likely to register the maximum CAGR from 2017 to 2025. It is likely to lead the global market, in terms of revenue, during the forecast period. This estimated dominance of the segment is attributable to technically efficient and high-resolution screening of tumors and easy detection of the breast cancer with the help of 3D images.
Based on end-user, the global contrast-enhanced digital mammography market can be segmented into hospitals, diagnostic laboratories, clinics, and others. The hospitals segment accounted for the maximum market share in 2016, which is attributable to improved reimbursement policies for diagnostic imaging procedures and availability of well-equipped health care facilities in hospitals. The rising investment by public and private players in the health care sector is estimated to propel the hospitals segment of the global contrast-enhanced digital mammography market during the forecast period.
Request Customization on Contrast-enhanced Digital Mammography (CEDM) Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=35984
Geographically, the global contrast-enhanced digital mammography market has been segmented into five major regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the maximum market share in 2016, which is attributable to the rising adoption of advanced diagnostic techniques for breast malignancy detection in the region and superiority of contrast-enhanced digital mammography over the standard MRI technique. On the other hand, Asia Pacific is likely to register the maximum CAGR from 2017 to 2025, owing to low cost of the contrast-enhanced digital mammography, shorter time required for the procedure as compared to standard MRI, and rapidly rising number of patients of breast cancer in the region. Increasing incidence of breast cancer in the U.S., and growing awareness of early detection and screening of breast cancer, are some of the major factors expected to drive the growth of the contrast-enhanced digital mammography market in North America during 2017-2025.
Pre Book Contrast-enhanced Digital Mammography (CEDM) Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=35984<ype=S
Prominent players operating in the global Contrast-enhanced Digital Mammography (CEDM) Market are Hologic, Inc., GE Healthcare, Planmed OY, and Allengers.
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad-hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453